Literature DB >> 8428580

The NF-kappa B precursor p105 and the proto-oncogene product Bcl-3 are I kappa B molecules and control nuclear translocation of NF-kappa B.

M Naumann1, F G Wulczyn, C Scheidereit.   

Abstract

We have examined the interaction of the NF-kappa B precursor p105 with NF-kappa B subunits. Similar to an I kappa B molecule, p105 associates in the cytoplasm with p50 or p65. Through this assembly, p105 efficiently blocks nuclear transfer of either subunit. Moreover, the p105 protein inhibits DNA binding of dimeric NF-kappa B subunits in a similar, but not identical, manner to its isolated C-terminal domain, which contains an ankyrin-like repeat domain (ARD). The proto-oncogene product Bcl-3 also controls nuclear translocation of p50, but not of p65. Hence, p50 can be retained in the cytoplasm via at least three distinct interactions: through direct interactions either with its own precursor, with Bcl-3 or indirectly through I kappa B alpha or -beta when attached to p65. We discuss a function of p105 as a cytoplasmic assembly unit for homo- and heteromeric NF-kappa B complexes and of Bcl-3 as an I kappa B with novel subunit specificity.

Entities:  

Mesh:

Substances:

Year:  1993        PMID: 8428580      PMCID: PMC413194          DOI: 10.1002/j.1460-2075.1993.tb05647.x

Source DB:  PubMed          Journal:  EMBO J        ISSN: 0261-4189            Impact factor:   11.598


  56 in total

1.  Similarity between cell-cycle genes of budding yeast and fission yeast and the Notch gene of Drosophila.

Authors:  L Breeden; K Nasmyth
Journal:  Nature       Date:  1987 Oct 15-21       Impact factor: 49.962

2.  A new technique for the assay of infectivity of human adenovirus 5 DNA.

Authors:  F L Graham; A J van der Eb
Journal:  Virology       Date:  1973-04       Impact factor: 3.616

3.  Cleavage of structural proteins during the assembly of the head of bacteriophage T4.

Authors:  U K Laemmli
Journal:  Nature       Date:  1970-08-15       Impact factor: 49.962

4.  Amino acid sequences common to rapidly degraded proteins: the PEST hypothesis.

Authors:  S Rogers; R Wells; M Rechsteiner
Journal:  Science       Date:  1986-10-17       Impact factor: 47.728

5.  Elution of proteins from sodium dodecyl sulfate-polyacrylamide gels, removal of sodium dodecyl sulfate, and renaturation of enzymatic activity: results with sigma subunit of Escherichia coli RNA polymerase, wheat germ DNA topoisomerase, and other enzymes.

Authors:  D A Hager; R R Burgess
Journal:  Anal Biochem       Date:  1980-11-15       Impact factor: 3.365

6.  Dorsal, an embryonic polarity gene in Drosophila, is homologous to the vertebrate proto-oncogene, c-rel.

Authors:  R Steward
Journal:  Science       Date:  1987-10-30       Impact factor: 47.728

7.  Accurate transcription initiation by RNA polymerase II in a soluble extract from isolated mammalian nuclei.

Authors:  J D Dignam; R M Lebovitz; R G Roeder
Journal:  Nucleic Acids Res       Date:  1983-03-11       Impact factor: 16.971

8.  Nucleic acid sequences of the oncogene v-rel in reticuloendotheliosis virus strain T and its cellular homolog, the proto-oncogene c-rel.

Authors:  K C Wilhelmsen; K Eggleton; H M Temin
Journal:  J Virol       Date:  1984-10       Impact factor: 5.103

9.  Replacement of insulin receptor tyrosine residues 1162 and 1163 compromises insulin-stimulated kinase activity and uptake of 2-deoxyglucose.

Authors:  L Ellis; E Clauser; D O Morgan; M Edery; R A Roth; W J Rutter
Journal:  Cell       Date:  1986-06-06       Impact factor: 41.582

10.  Purification of KBF1, a common factor binding to both H-2 and beta 2-microglobulin enhancers.

Authors:  O Yano; J Kanellopoulos; M Kieran; O Le Bail; A Israël; P Kourilsky
Journal:  EMBO J       Date:  1987-11       Impact factor: 11.598

View more
  61 in total

Review 1.  The ubiquitin-proteasome pathway and proteasome inhibitors.

Authors:  J Myung; K B Kim; C M Crews
Journal:  Med Res Rev       Date:  2001-07       Impact factor: 12.944

2.  Alternative nuclear functions for NF-κB family members.

Authors:  Lluís Espinosa; Anna Bigas; Maria Carmen Mulero
Journal:  Am J Cancer Res       Date:  2011-02-16       Impact factor: 6.166

Review 3.  NF-κB, the first quarter-century: remarkable progress and outstanding questions.

Authors:  Matthew S Hayden; Sankar Ghosh
Journal:  Genes Dev       Date:  2012-02-01       Impact factor: 11.361

4.  CSN controls NF-kappaB by deubiquitinylation of IkappaBalpha.

Authors:  Katrin Schweitzer; Przemyslaw M Bozko; Wolfgang Dubiel; Michael Naumann
Journal:  EMBO J       Date:  2007-02-22       Impact factor: 11.598

5.  Constitutive expression of Bc1-3 in thymocytes increases the DNA binding of NF-kappaB1 (p50) homodimers in vivo.

Authors:  J H Caamaño; P Perez; S A Lira; R Bravo
Journal:  Mol Cell Biol       Date:  1996-04       Impact factor: 4.272

6.  Tax induces nuclear translocation of NF-kappa B through dissociation of cytoplasmic complexes containing p105 or p100 but does not induce degradation of I kappa B alpha/MAD3.

Authors:  E Muñoz; G Courtois; P Veschambre; P Jalinot; A Israël
Journal:  J Virol       Date:  1994-12       Impact factor: 5.103

Review 7.  The multifaceted NF-kB: are there still prospects of its inhibition for clinical intervention in pediatric central nervous system tumors?

Authors:  Mariana Medeiros; Marina Ferreira Candido; Elvis Terci Valera; María Sol Brassesco
Journal:  Cell Mol Life Sci       Date:  2021-07-31       Impact factor: 9.261

Review 8.  Functional diversity of ankyrin repeats in microbial proteins.

Authors:  Souhaila Al-Khodor; Christopher T Price; Awdhesh Kalia; Yousef Abu Kwaik
Journal:  Trends Microbiol       Date:  2009-12-03       Impact factor: 17.079

9.  BCL3 encodes a nuclear protein which can alter the subcellular location of NF-kappa B proteins.

Authors:  Q Zhang; J A Didonato; M Karin; T W McKeithan
Journal:  Mol Cell Biol       Date:  1994-06       Impact factor: 4.272

10.  Constitutive NF-kappa B activity in neurons.

Authors:  C Kaltschmidt; B Kaltschmidt; H Neumann; H Wekerle; P A Baeuerle
Journal:  Mol Cell Biol       Date:  1994-06       Impact factor: 4.272

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.